CliffBio
small molecule

GLYCINE 1.5% IN PLASTIC CONTAINER

GLYCINE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameGLYCINE 1.5% IN PLASTIC CONTAINER
Active ingredientGLYCINE
Strength1.5GM/100ML
Dosage formSOLUTION
RouteIRRIGATION
ModalitySmall molecule
FDA approvalFebruary 1982
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.